Tag: Avertix Medical

Avertix’s Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients

EATONTOWN, N.J., Feb. 14, 2025 /PRNewswire/ — Avertix Medical, Inc. (“Avertix” or the “Company”), the developer of The Guardian® system – the world’s first real-time, continuous heart attack detection and patient alerting system today announced compelling new data confirming the…

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) — Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation […]

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

EATONTOWN, N.J. and TRINITY, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) — Avertix Medical, Inc. (“Avertix” or the “Company”), a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and the Heart & Rhythm Institute of Trinity, an ambulatory surgery […]

Angel Medical Systems, Creator of the Guardian™, First Implantable Cardiac Alert System, Changes Name to Avertix Medical Inc. and Welcomes New CEO and CFO to Drive Continued Growth and Success

New company name chosen to represent focus on ‘averting’ serious cardiac complications with state-of-the-art Guardian™ monitoring and alerting system President and CEO Tim Moran and Chief Financial Officer Philip Tom to join Executive Chairman Ross Haghighat in leadership roles EATONTOWN, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Angel Medical Systems […]